Telmisartan and hyrdochlorothiazide recalls
The FDA has published 3 recalls involving Telmisartan and hyrdochlorothiazide since 2019. The latest was reported on 20 Mar 2019. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 20 Mar 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why telmisartan and hyrdochlorothiazide is recalled
Companies
By year
All telmisartan and hyrdochlorothiazide recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Telmisartan and Hyrdochlorothiazide Tablets recalled | Macleods Pharma Usa | Potency & Assay | Nationwide |
| Drug | CLASS II | Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg recalled | Macleods Pharma Usa | Potency & Assay | Nationwide |
| Drug | CLASS II | Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg recalled | Macleods Pharma Usa | Potency & Assay | Nationwide |
Should you stop taking Telmisartan and hyrdochlorothiazide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.